drugset
drugset / Trial / NCT01308593

Brow Enhancement Study

NCT01308593 ↗

Phase 4 Completed 30 enrolled Skin Care and Laser Physicians of Beverly Hills
RandomizedCrossoverOpen-labelTreatment

Summary

Investigation into brow aesthetics using Botox in Conjunction with Juvederm XC as evaluated by patient satisfaction

Timeline

Start
2011-03
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 26 unknown —

Indications

ptosis